Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MITANYSE:NREFNASDAQ:OACCNYSE:TCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMITAColiseum Acquisition$11.51$11.51$9.00▼$13.70$63.73M0.0321,603 shsN/ANREFNexPoint Real Estate Finance$13.65-2.4%$14.50$12.14▼$18.09$247.82M1.1843,978 shs99,285 shsOACCOaktree Acquisition Corp. III Life Sciences$10.41-0.3%$10.48$9.95▼$10.85$234.13MN/A27,919 shs181 shsTCITranscontinental Realty Investors$45.33+1.5%$37.29$25.50▼$46.74$386.01M0.453,406 shs3,222 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMITAColiseum Acquisition0.00%0.00%0.00%0.00%+5.02%NREFNexPoint Real Estate Finance-2.43%-1.37%-10.40%+7.06%+3.17%OACCOaktree Acquisition Corp. III Life Sciences-0.29%-0.38%-1.14%+2.56%+1,040,999,900.00%TCITranscontinental Realty Investors+1.45%+5.22%+20.75%+61.35%+59.61%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMITAColiseum AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ANREFNexPoint Real Estate Finance3.5948 of 5 stars1.03.01.70.01.95.03.8OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ATCITranscontinental Realty Investors1.7561 of 5 stars0.03.00.02.12.73.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMITAColiseum Acquisition 0.00N/AN/AN/ANREFNexPoint Real Estate Finance 2.00Hold$14.506.23% UpsideOACCOaktree Acquisition Corp. III Life Sciences 0.00N/AN/AN/ATCITranscontinental Realty Investors 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MITA, NREF, TCI, and OACC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/2/2025NREFNexPoint Real Estate FinanceKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$15.00 ➝ $14.50(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMITAColiseum AcquisitionN/AN/A$0.37 per share31.40($0.69) per shareN/ANREFNexPoint Real Estate Finance$72.51M3.33$3.98 per share3.43$19.27 per share0.71OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AN/ATCITranscontinental Realty Investors$47.07M8.32$2.16 per share20.98$98.71 per share0.46Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMITAColiseum Acquisition$3.10MN/A0.00∞N/AN/A-16.55%-9.51%N/ANREFNexPoint Real Estate Finance$29.19M$2.276.016.15N/A75.32%24.54%1.43%7/30/2025 (Estimated)OACCOaktree Acquisition Corp. III Life SciencesN/AN/A0.00∞N/AN/AN/AN/AN/ATCITranscontinental Realty Investors$5.86M$0.9149.81∞N/A16.81%0.57%0.46%8/6/2025 (Estimated)Latest MITA, NREF, TCI, and OACC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025TCITranscontinental Realty InvestorsN/A$0.17N/A$0.53N/A$12.01 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMITAColiseum AcquisitionN/AN/AN/AN/AN/ANREFNexPoint Real Estate Finance$2.0014.65%N/A88.11%N/AOACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/ATCITranscontinental Realty InvestorsN/AN/AN/AN/AN/ALatest MITA, NREF, TCI, and OACC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/29/2025NREFNexPoint Real Estate Financequarterly$0.5013.88%6/13/20256/13/20256/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMITAColiseum AcquisitionN/A0.010.01NREFNexPoint Real Estate Finance1.66230.81230.81OACCOaktree Acquisition Corp. III Life SciencesN/AN/AN/ATCITranscontinental Realty InvestorsN/A1.031.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMITAColiseum Acquisition25.79%NREFNexPoint Real Estate Finance67.79%OACCOaktree Acquisition Corp. III Life SciencesN/ATCITranscontinental Realty InvestorsN/AInsider OwnershipCompanyInsider OwnershipMITAColiseum Acquisition47.70%NREFNexPoint Real Estate Finance54.00%OACCOaktree Acquisition Corp. III Life SciencesN/ATCITranscontinental Realty Investors86.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMITAColiseum Acquisition2,0215.54 million3.35 millionNot OptionableNREFNexPoint Real Estate Finance117.71 million8.15 millionOptionableOACCOaktree Acquisition Corp. III Life SciencesN/A22.42 millionN/AN/ATCITranscontinental Realty InvestorsN/A8.64 million1.19 millionNot OptionableMITA, NREF, TCI, and OACC HeadlinesRecent News About These CompaniesTranscontinental Realty Investors (NYSE:TCI) Shares Cross Above 200-Day Moving Average - Time to Sell?July 4, 2025 | marketbeat.comTranscontinental Realty Investors (NYSE:TCI) Stock Price Crosses Above Two Hundred Day Moving Average - What's Next?June 26, 2025 | marketbeat.comTranscontinental Realty Investors (NYSE:TCI) Shares Cross Above 200-Day Moving Average - Should You Sell?June 18, 2025 | marketbeat.comTranscontinental Realty Inc falls -9.1%June 11, 2025 | msn.comTranscontinental Realty Investors (NYSE:TCI) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?June 10, 2025 | marketbeat.comTranscontinental Realty Investors' (NYSE:TCI) Shareholders May Want To Dig Deeper Than Statutory ProfitMay 15, 2025 | finance.yahoo.com5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears (TCI)May 14, 2025 | insidertrades.comTranscontinental Realty Investors First Quarter 2025 Earnings: EPS: US$0.54 (vs US$0.29 in 1Q 2024)May 10, 2025 | finance.yahoo.comTranscontinental Realty Investors, Inc. Reports Earnings for Quarter Ended March 31, 2025 | TCI ...May 8, 2025 | gurufocus.comRealty Invest Transcontinental Acquires 1,000 Shares of Transcontinental Realty Investors, Inc. (NYSE:TCI) StockMay 6, 2025 | insidertrades.comTranscontinental Realty Investors, Inc. (NYSE:TCI) Major Shareholder Acquires $26,430.00 in StockApril 8, 2025 | insidertrades.comTranscontinental Realty Investors Full Year 2024 Earnings: EPS: US$0.68 (vs US$0.69 in FY 2023)March 22, 2025 | finance.yahoo.comMarch 20, 2025 | gurufocus.comLearn to Evaluate (TCI) using the ChartsFebruary 9, 2025 | news.stocktradersdaily.comNInsider Buying: Transcontinental Realty Investors, Inc. (NYSE:TCI) Major Shareholder Acquires 21,678 Shares of StockFebruary 5, 2025 | insidertrades.comTranscontinental realty acquires $390k in income opportunity sharesFebruary 4, 2025 | msn.comTCI stock touches 52-week low at $25.98 amid market challengesJanuary 31, 2025 | msn.comTranscontinental Realty Investors, Inc Announces Number of Shares Received in Tender Offer Which Expired January 29, 2025January 30, 2025 | businesswire.com(TCI) Investment Analysis and AdviceJanuary 30, 2025 | news.stocktradersdaily.comN(TCI) Investment Analysis and AdviceJanuary 30, 2025 | news.stocktradersdaily.comNWhere are the Opportunities in (TCI)January 7, 2025 | news.stocktradersdaily.comNNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMITA, NREF, TCI, and OACC Company DescriptionsColiseum Acquisition NASDAQ:MITA$11.51 0.00 (0.00%) As of 06/26/2025Coliseum Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Las Vegas, Nevada.NexPoint Real Estate Finance NYSE:NREF$13.65 -0.34 (-2.43%) Closing price 07/7/2025 03:59 PM EasternExtended Trading$13.76 +0.12 (+0.84%) As of 07/7/2025 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NexPoint Real Estate Finance, Inc. operates as a commercial mortgage real estate investment trust in the United States. It focuses on originating, structuring, and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multifamily and single-family rental commercial mortgage-backed securities securitizations, multifamily structured credit risk notes, and mortgage-backed securities or target assets. The company has elected to be taxed as a real estate investment trust (REIT) and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. NexPoint Real Estate Finance, Inc. was incorporated in 2019 and is based in Dallas, Texas.Oaktree Acquisition Corp. III Life Sciences NASDAQ:OACC$10.41 -0.03 (-0.29%) As of 07/7/2025 09:30 AM EasternOaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.Transcontinental Realty Investors NYSE:TCI$45.33 +0.65 (+1.45%) As of 07/7/2025 03:43 PM EasternTranscontinental Realty Investors, Inc., a Dallas-based real estate investment company, holds a diverse portfolio of equity real estate located across the U.S., including office buildings, apartments, shopping centers, and developed and undeveloped land. The Company invests in real estate through direct ownership, leases and partnerships and invests in mortgage loans on real estate. The Company also holds mortgage receivables. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
